期刊文献+

类风湿因子、抗角蛋白抗体、C反应蛋白和抗环瓜氨酸抗体联合检测在类风湿关节炎诊断中的临床意义 被引量:3

Diagnostic values of combined determination of serum rheumatoid factor,antikeratin antibody,C reaction protein and anti-CCP antibody in patients with rheumatoid arthritis
暂未订购
导出
摘要 目的探讨联合检测类风湿因子(RF)、抗角蛋白抗体(AKA)、C反应蛋白(CRP)和抗环瓜氨酸肽(抗-CCP)抗体诊断类风湿关节炎(RA)的临床意义。方法检测72例RA患者和73例其他风湿类疾病患者的RF、AKA和CRP以及抗-CCP抗体。结果 72例患者血清中,RF灵敏度和特异性分别为64.8%和75.6%,AKA灵敏度和特异性分别为73.5%和94.7%,CRP灵敏度和特异性分别为85.2%和34.7%,抗-CCP抗体灵敏度和特异性分别为75.6%和92.8%,4项联合检测灵敏度和特异性分别为98.7%和93.8%。结论 RF、AKA、CRP和抗-CCP抗体4项指标联合检测可明显提高诊断RA的敏感性,有助于RA的诊断。 Objective To evaluate the diagnostic value of combined determination of serum rheumatoid factor(RF), antikeratin antibody(AKA) c-reaction protein(CRP) and anti-cyclic citrulline peptide(anti-CCP) anti-body in patients with rheumatoid arthritis(RA). Methods All the level of RF, AKA, CRP and anti-CCP were determined in 72 patients with RA and in 73 patients with other rheumatic diseases. Results The diagnostic sensitivity of RF, AKA, CRP and anti-CCP were 64.8 %, 73.5 %, 85.2 % and 75.6 %, respectively, and the specificity were 75.6 %, 94. 7 %, 34.7 % and 92.8 %, respectively. The specificity was 92.8 % and the sensitivity was 98.7 % with combined determination of RF, CRP and anti-CCP. Conclusion The combination of RF, AKA, CRP and anti-CCP may offer clinical benefits for diagnosis of RA and can significantly improve the sensitivity to diagnose RA.
作者 缪瑾
出处 《实用临床医药杂志》 CAS 2012年第21期124-125,128,共3页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11220162)
关键词 类风湿关节炎 类风湿因子 C反应蛋白 抗环瓜氨酸肽抗体 rheumatoid arthritis rheumatoid factor C-reaction protein anti-cyclic citrulline peptide antibody
  • 相关文献

参考文献7

二级参考文献33

  • 1周彬,朱静,刘建,龙武彬,吴晓丹,程佳,吴侗.抗环瓜氨酸肽抗体检测在类风湿关节炎中的诊断及预后意义探讨[J].中华风湿病学杂志,2004,8(6):360-362. 被引量:51
  • 2陈雪初,肖荣.类风湿因子与抗角蛋白抗体联合检测类风湿关节炎的诊断探讨[J].中国现代医学杂志,2005,15(8):1265-1266. 被引量:10
  • 3曾瑜,陈明,蔡美珠,刘琦,顾耀林,王开正.抗环瓜氨酸肽抗体和类风湿因子联合测定对类风湿关节炎的诊断价值[J].中国临床医学,2006,13(6):1022-1023. 被引量:14
  • 4[4]Schellekens GA,De Jong BA,Van Den,et al.Citru uine is an essential constituent of antigenic determinants recognized by rheumatoid arthritis.spec 6c autoantibodies.J Clin Invest,1998,101 (2) :273-281.
  • 5[5]Kroote JJA,De Jong BAW,Van Leeuwen MMA,et al.The prognostic vahue of anti-cyclic citrullinated peptide antibody in patients with recent-onsetrheumatoid arthritis.ArthritisRheum,2000,43(10) :1831-1835.
  • 6Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheu-matism Association 1987 revised criteria for the classificationof rheumatoid arthritis[J]. Arthritis Rheum, 1988,31 (3) :315-324.
  • 7Schellekens GA,Visser H,De Jong BA,et al The diagnosticproperties of rheumatoid arthritis antibodies recognizing a eyclic citrullinated peptide[J]. Arthritis Rheum, 2000,43 ( 1 ) :155-163.
  • 8Kroot EJ,De Jong BA, Van Leeuwen MA, et al. The larognostic value of anticyclic citrullinated peptide antibody in patientswith recent onset rheumatoid arthritis[J]. Arthritis Rheum,2000,43 (12):1831-1835.
  • 9Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy ofthe anticitrulline antibody assay for rheumatoid arthritis [J].Clinchem,2001,47(6):1089-1093.
  • 10叶任高.内科学[M] 第5版[M].北京:人民卫生出版社,2002.804.

共引文献88

同被引文献21

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部